A pilot study for the efficacy of the non-benzodiazepine hypnotic or orexin receptor antagonist on insomnia in major depressive patients unresponsive to benzodiazepine hypnotic treatment: a randomized open-label trial.
Phase of Trial: Phase II
Latest Information Update: 29 Mar 2018
At a glance
- Drugs Eszopiclone (Primary) ; Suvorexant (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 27 Mar 2018 Status changed from not yet recruiting to recruiting.
- 30 Jan 2018 New trial record